KEE GAD views R&D capabilities as the vital component of its business strategy that will provide the company with a long-term competitive advantage. Research is crucial to KEE GAD. The Company’s multi-disciplinary R&D centre at Naraina Industrial area houses dedicated facilities for innovative research in its areas of expertise. The R&D unit is recognized by the Department of Scientific & Industrial Research of the Ministry of Science & Technology, Govt. of India. KEE GAD’s major strengths and core competencies lies in the development and commercialization of highly pure diagnostic reagents for use in all kinds of auto and semi automatic analyzers; development of rapid diagnostic devices for assessing the status of the patients for various physiological conditions; manipulation of natural bio-polymers for drug delivery; development and production of recombinant therapeutics; and introduction of novel nano-medicines. The company has established collaboration with a number of institutions for developing novel biological materials and nano-medicines. The company has also interest to develop therapeutic vaccines to combat HIV infection; in this direction the company has teamed up with a reputed foreign academic institute. The company also undertakes contract research and is eager to team up with business partners for conducting research in specific areas under contractual terms. The company has published two research papers recently as per details provided below:

1) Probiotic-assisted colon-specifc delivery of diclofenac sodium from guar gum matrix tablets: In vitro evaluation: Prasanta Kumar Ghosh,Vipin Bihari Gupta, Bhavik Gondoliya, Mahendra Singh Rathore, Asian Journal of Pharmaceutics, Volume 4 Issue / 4 / Oct-Dec 2010, pp 173-178

2) Wound-healing potential of aqueous and ethanolic extracts of apamarga leaves: P. K. Ghosh, V. B. Gupta, M. S. Rathore, Iqbal Hussain, International Journal of Green Pharmacy, Volume 5 Issue 1 January - March 2011, pp 12-15.